Q3 Earnings Forecast for AptarGroup Issued By William Blair

Key Points

• William Blair has revised its Q3 2025 earnings per share (EPS) estimate for AptarGroup down from $1.71 to $1.58, while the consensus estimate for the full year remains at $5.57 EPS.
• AptarGroup recently reported Q2 earnings of $1.66 per share, exceeding consensus estimates and showing a revenue increase of 6.1% year-over-year to $966.01 million.
• Despite recent stock price adjustments by other analysts, AptarGroup maintains a consensus rating of "Buy" with a target price of $174.60.

AptarGroup, Inc. (NYSE:ATR - Free Report) - Investment analysts at William Blair decreased their Q3 2025 earnings per share (EPS) estimates for shares of AptarGroup in a report issued on Tuesday, August 5th. William Blair analyst M. Larew now expects that the industrial products company will earn $1.58 per share for the quarter, down from their prior forecast of $1.71. The consensus estimate for AptarGroup's current full-year earnings is $5.57 per share. William Blair also issued estimates for AptarGroup's Q3 2026 earnings at $1.71 EPS.

AptarGroup (NYSE:ATR - Get Free Report) last issued its earnings results on Thursday, July 31st. The industrial products company reported $1.66 earnings per share for the quarter, beating analysts' consensus estimates of $1.58 by $0.08. AptarGroup had a return on equity of 15.39% and a net margin of 10.84%. The company had revenue of $966.01 million for the quarter, compared to the consensus estimate of $954.06 million. During the same quarter in the prior year, the company earned $1.41 EPS. The firm's quarterly revenue was up 6.1% on a year-over-year basis.

ATR has been the topic of a number of other research reports. Raymond James Financial restated an "outperform" rating and issued a $172.00 price objective (down previously from $182.00) on shares of AptarGroup in a report on Monday, August 4th. Wells Fargo & Company restated an "overweight" rating and issued a $153.00 price objective (down previously from $173.00) on shares of AptarGroup in a report on Monday, August 4th. Finally, Wall Street Zen upgraded AptarGroup from a "hold" rating to a "buy" rating in a report on Wednesday, May 14th. One research analyst has rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Buy" and a consensus target price of $174.60.

AptarGroup Stock Up 0.3%

NYSE:ATR traded up $0.42 during mid-day trading on Wednesday, reaching $140.91. The stock had a trading volume of 428,743 shares, compared to its average volume of 449,430. The business's 50 day moving average is $153.97 and its 200 day moving average is $150.97. AptarGroup has a fifty-two week low of $130.85 and a fifty-two week high of $178.03. The stock has a market cap of $9.28 billion, a P/E ratio of 24.25, a PEG ratio of 2.92 and a beta of 0.57. The company has a debt-to-equity ratio of 0.20, a current ratio of 1.21 and a quick ratio of 0.83.

AptarGroup Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, August 14th. Shareholders of record on Thursday, July 24th will be issued a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a yield of 1.3%. The ex-dividend date is Thursday, July 24th. AptarGroup's dividend payout ratio (DPR) is 30.98%.

Insider Buying and Selling

In other news, insider Hedi Tlili sold 3,614 shares of the stock in a transaction that occurred on Friday, May 16th. The stock was sold at an average price of $155.96, for a total value of $563,639.44. Following the completion of the sale, the insider directly owned 9,379 shares of the company's stock, valued at approximately $1,462,748.84. This represents a 27.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Xiangwei Gong sold 7,000 shares of the stock in a transaction that occurred on Thursday, May 22nd. The shares were sold at an average price of $156.49, for a total value of $1,095,430.00. Following the completion of the sale, the insider directly owned 10,265 shares of the company's stock, valued at $1,606,369.85. This represents a 40.54% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,585 shares of company stock worth $2,418,028. 0.68% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On AptarGroup

Several hedge funds have recently modified their holdings of ATR. Simplex Trading LLC lifted its position in AptarGroup by 107.4% in the first quarter. Simplex Trading LLC now owns 224 shares of the industrial products company's stock worth $33,000 after purchasing an additional 116 shares during the period. SVB Wealth LLC bought a new position in AptarGroup in the first quarter worth $33,000. MassMutual Private Wealth & Trust FSB lifted its position in AptarGroup by 155.0% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 278 shares of the industrial products company's stock worth $41,000 after purchasing an additional 169 shares during the period. Northwestern Mutual Wealth Management Co. lifted its position in AptarGroup by 281.9% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 317 shares of the industrial products company's stock worth $47,000 after purchasing an additional 234 shares during the period. Finally, Thurston Springer Miller Herd & Titak Inc. lifted its position in AptarGroup by 164.8% in the second quarter. Thurston Springer Miller Herd & Titak Inc. now owns 331 shares of the industrial products company's stock worth $52,000 after purchasing an additional 206 shares during the period. 88.52% of the stock is owned by institutional investors.

AptarGroup Company Profile

AptarGroup, Inc designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments.